Aakaar Medical Technologies Ltd., established in 2013, operates in the Medical Equipment & Accessories sector. The company's IPO opened on June 20, 2025 and closed on June 24, 2025, with an issue ... Read more
Incorporated in the year 2013, We are a medical aesthetic company dealing in a wide range of aesthetics & specialised cosmetic products & devices. Product range includes both Own brands (domestically manufactured products via loan licensing/third party manufacturers) and distribution of ... Read more
| Investors Category | Shares Offered |
|---|---|
| Anchor Investors | 10,67,200 (28.46%) |
| Market Makers | 1,88,800 (5.03%) |
| Non Institutional Investors | 5,34,400 (14.25%) |
| Qualified Institutional Buyers (QIBs) | 7,12,000 (18.98%) |
| Retail Individual Investors (RIIs) | 12,48,000 (33.28%) |
| Year End | Revenue | PAT | Reserves & Surplus |
|---|---|---|---|
| 31 Mar 2025 | 61.76 Cr | 6.04 Cr | 12.78 Cr |
| 31 Mar 2024 | 46.27 Cr | 2.87 Cr | 11.84 Cr |
| 31 Mar 2023 | 32.88 Cr | 2.15 Cr | 8.96 Cr |
1. Funding working capital requirements of our Company
2. General corporate purposes
| Pricing Details | BSE | NSE |
|---|---|---|
| Issue Price | - | ₹ 72.00 |
| Open | - | ₹ 75.00 |
| Low | - | ₹ 71.25 |
| High | - | ₹ 75.00 |
| Last Trade | - | ₹ 71.25 |
1. Dilip Ramesh Meswani
2. Bindi Dilip Meswani
The global medical aesthetics and cosmetic dermatology market was valued at USD 35.9 Bn in CY2024 and is projected to reach USD 57.4 Bn by CY2030. The Indian medical aesthetics and cosmetic dermatology market generated a revenue of USD 283.9 Mn in CY2024 @ CAGR of 13.9% during the forecasted ... Read more
When does Aakaar Medical Technologies Ltd. IPO opens and closes?
What is the size of Aakaar Medical Technologies Ltd. IPO?
What is the price range of Aakaar Medical Technologies Ltd. IPO?
What is the minimum investment and lot size required for the Aakaar Medical Technologies Ltd. IPO?
When is Aakaar Medical Technologies Ltd. IPO listing date?
What is the objective of Aakaar Medical Technologies Ltd. IPO?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article